For research use only. Not for therapeutic Use.
GAPDH inhibitor compound F8 is a non-cysteine-targeting covalent GAPDH inhibitor.
Keywords: GAPDH inhibitor compound F8 | Supplier | GAPDH inhibitor | CAS [252212-58-1] | Glyceraldehyde 3-phosphate | GAPDH | Inhibitor | Enzymes | Glycolysis | Glyceraldehyde-3-phosphate dehydrogenase
Catalog Number | I047683 |
CAS Number | 252212-58-1 |
Molecular Formula | C20H18N2O5 |
Purity | ≥95% |
IUPAC Name | 2,5-bis[3-(oxiran-2-ylmethoxy)phenyl]-1,3,4-oxadiazole |
InChI | InChI=1S/C20H18N2O5/c1-3-13(7-15(5-1)23-9-17-11-25-17)19-21-22-20(27-19)14-4-2-6-16(8-14)24-10-18-12-26-18/h1-8,17-18H,9-12H2 |
SMILES | C1C(O1)COC2=CC=CC(=C2)C3=NN=C(O3)C4=CC(=CC=C4)OCC5CO5 |
Reference | Y Jung et al. Discovery of Non-Cysteine-Targeting Covalent Inhibitors by Activity-Based Proteomic Screening with a Cysteine-Reactive Probe. ACS Chem Biol. 2022 Feb 18;17(2):340-347. |